These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 14587077)

  • 41. Electrochemical and spectral studies on the reductive nitrosylation of water-soluble iron porphyrin.
    Trofimova NS; Safronov AY; Ikeda O
    Inorg Chem; 2003 Mar; 42(6):1945-51. PubMed ID: 12639128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanistic insight into the aromatic hydroxylation by high-valent iron(IV)-oxo porphyrin pi-cation radical complexes.
    Kang MJ; Song WJ; Han AR; Choi YS; Jang HG; Nam W
    J Org Chem; 2007 Aug; 72(16):6301-4. PubMed ID: 17622172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study of the catalytic activity of [Mn(II)(bpy)2Cl2] and [Mn2(III/IV)(mu-O)2(bpy)4](ClO4)3 in the H2O2 induced oxidation of organic dyes in carbonate buffered aqueous solution.
    Rothbart S; Ember E; van Eldik R
    Dalton Trans; 2010 Apr; 39(13):3264-72. PubMed ID: 20449456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Catalase-peroxidase activity of iron(III)-TAML activators of hydrogen peroxide.
    Ghosh A; Mitchell DA; Chanda A; Ryabov AD; Popescu DL; Upham EC; Collins GJ; Collins TJ
    J Am Chem Soc; 2008 Nov; 130(45):15116-26. PubMed ID: 18928252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resonance Raman spectroscopy of oxoiron(IV) porphyrin pi-cation radical and oxoiron(IV) hemes in peroxidase intermediates.
    Terner J; Palaniappan V; Gold A; Weiss R; Fitzgerald MM; Sullivan AM; Hosten CM
    J Inorg Biochem; 2006 Apr; 100(4):480-501. PubMed ID: 16513173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intramolecular energy transfer involving heisenberg spin-coupled dinuclear iron-oxo complexes.
    Picraux LB; Smeigh AL; Guo D; McCusker JK
    Inorg Chem; 2005 Oct; 44(22):7846-59. PubMed ID: 16241134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of solvent composition on the kinetics of cyclooctene epoxidation by hydrogen peroxide catalyzed by iron(III) [tetrakis(pentafluorophenyl)] porphyrin chloride [(F20TPP)FeCl].
    Stephenson NA; Bell AT
    Inorg Chem; 2006 Mar; 45(6):2758-66. PubMed ID: 16529501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct evidence for an iron(IV)-oxo porphyrin pi-cation radical as an active oxidant in catalytic oxygenation reactions.
    Han AR; Jin Jeong Y; Kang Y; Lee JY; Sook Seo M; Nam W
    Chem Commun (Camb); 2008 Mar; (9):1076-8. PubMed ID: 18292895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iron(III) complexes of tripodal monophenolate ligands as models for non-heme catechol dioxygenase enzymes: correlation of dioxygenase activity with ligand stereoelectronic properties.
    Mayilmurugan R; Visvaganesan K; Suresh E; Palaniandavar M
    Inorg Chem; 2009 Sep; 48(18):8771-83. PubMed ID: 19694480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reactivity of a (mu-oxo)(mu-hydroxo)diiron(III) diamond core with water, urea, substituted ureas, and acetamide.
    Taktak S; Kryatov SV; Rybak-Akimova EV
    Inorg Chem; 2004 Nov; 43(22):7196-209. PubMed ID: 15500359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EPR and ENDOR studies of cryoreduced compounds II of peroxidases and myoglobin. Proton-coupled electron transfer and protonation status of ferryl hemes.
    Davydov R; Osborne RL; Kim SH; Dawson JH; Hoffman BM
    Biochemistry; 2008 May; 47(18):5147-55. PubMed ID: 18407661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anion binding to a ferric porphyrin complexed with per-O-methylated beta-cyclodextrin in aqueous solution.
    Kano K; Kitagishi H; Tamura S; Yamada A
    J Am Chem Soc; 2004 Nov; 126(46):15202-10. PubMed ID: 15548017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iron(III) complex of a crown ether-porphyrin conjugate and reversible binding of superoxide to its Iron(II) form.
    Dürr K; Macpherson BP; Warratz R; Hampel F; Tuczek F; Helmreich M; Jux N; Ivanović-Burmazović I
    J Am Chem Soc; 2007 Apr; 129(14):4217-28. PubMed ID: 17371019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural, NMR, and EPR studies of S = (1)/(2) and S = (3)/(2) Fe(III) bis(4-cyanopyridine) complexes of dodecasubstituted porphyrins.
    Yatsunyk LA; Walker FA
    Inorg Chem; 2004 Jan; 43(2):757-77. PubMed ID: 14731040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrochemical generation of free nitric oxide from nitrite catalyzed by iron meso-tetrakis(4-N-methylpyridiniumyl)porphyrin.
    Chi Y; Chen J; Aoki K
    Inorg Chem; 2004 Dec; 43(26):8437-46. PubMed ID: 15606192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends in substrate hydroxylation reactions by heme and nonheme iron(IV)-oxo oxidants give correlations between intrinsic properties of the oxidant with barrier height.
    de Visser SP
    J Am Chem Soc; 2010 Jan; 132(3):1087-97. PubMed ID: 20041691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cobalt(IV) corroles as catalysts for the electroreduction of O2: reactions of heterobimetallic dyads containing a face-to-face linked Fe(III) or Mn(III) porphyrin.
    Kadish KM; Frémond L; Burdet F; Barbe JM; Gros CP; Guilard R
    J Inorg Biochem; 2006 Apr; 100(4):858-68. PubMed ID: 16516296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the axial ligand on the reactivity of the oxoiron(IV) porphyrin π-cation radical complex: higher stabilization of the product state relative to the reactant state.
    Takahashi A; Yamaki D; Ikemura K; Kurahashi T; Ogura T; Hada M; Fujii H
    Inorg Chem; 2012 Jul; 51(13):7296-305. PubMed ID: 22716193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probing the cytochrome P450-like reactivity of high-valent oxo iron intermediates in the gas phase.
    Crestoni ME; Fornarini S
    Inorg Chem; 2005 Jul; 44(15):5379-87. PubMed ID: 16022536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fenton-like oxidation of Rhodamine B in the presence of two types of iron (II, III) oxide.
    Xue X; Hanna K; Deng N
    J Hazard Mater; 2009 Jul; 166(1):407-14. PubMed ID: 19167810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.